Timothy M Shannon Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 4 days, 9 hours ago
Timothy M Shannon has an estimated net worth of at least $47.3 million*, as of July 2, 2025. They own 1.7 million shares of ARVN stock. They have sold 400,000 shares of ARVN stock since 2021, for an estimated $34.5 million.
Timothy M Shannon $ARVN SEC Form 4 Insider Trading
Timothy M Shannon has filed a total of 25 insider trades in $ARVN since 2021. Their most recent trade was a sale of 2,030 shares, made on Sep 07, 2021. Their largest trade was a sale of 47,166 shares, made on Aug 31, 2021. We estimate that they now own 1.7 million shares of $ARVN, worth an estimated $12.8 million.
Insider Trading at $ARVN
There have been a total of 128 insider trades reported at $ARVN since 2021, with 0 shares purchased and 1.5 million shares sold. The most active insider traders in $ARVN stock have been John G Houston, Ian Taylor, and Ronald Peck. The most recent trade was a sale of 5,700 shares reported by Andrew Saik (Chief Financial Officer), made on Jun 24, 2025.
History of Insider Stock Trades by Timothy M Shannon
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
ARVN
|
Sale | 2,030 | Sep 07, 2021 | Sept. 26, 2021, 8 p.m. |
|
ARVN
|
Sale | 1,599 | Aug 23, 2021 | Sept. 26, 2021, 8 p.m. |
|
ARVN
|
Sale | 4,568 | Aug 24, 2021 | Sept. 26, 2021, 8 p.m. |
|
ARVN
|
Sale | 4,635 | Aug 24, 2021 | Sept. 26, 2021, 8 p.m. |
|
ARVN
|
Sale | 14,267 | Aug 25, 2021 | Sept. 26, 2021, 8 p.m. |
|
ARVN
|
Sale | 11,712 | Aug 26, 2021 | Sept. 26, 2021, 8 p.m. |
|
ARVN
|
Sale | 42,655 | Aug 27, 2021 | Sept. 26, 2021, 8 p.m. |
|
ARVN
|
Sale | 2,371 | Aug 27, 2021 | Sept. 26, 2021, 8 p.m. |
|
ARVN
|
Sale | 24,607 | Aug 30, 2021 | Sept. 26, 2021, 8 p.m. |
|
ARVN
|
Sale | 25,469 | Aug 30, 2021 | Sept. 26, 2021, 8 p.m. |
|
ARVN
|
Sale | 7,581 | Aug 30, 2021 | Sept. 26, 2021, 8 p.m. |
|
ARVN
|
Sale | 1,181 | Aug 30, 2021 | Sept. 26, 2021, 8 p.m. |
|
ARVN
|
Sale | 47,166 | Aug 31, 2021 | Sept. 26, 2021, 8 p.m. |
|
ARVN
|
Sale | 12,189 | Aug 31, 2021 | Sept. 26, 2021, 8 p.m. |
|
ARVN
|
Sale | 18,821 | Sep 01, 2021 | Sept. 26, 2021, 8 p.m. |
|
ARVN
|
Sale | 29,478 | Sep 01, 2021 | Sept. 26, 2021, 8 p.m. |
|
ARVN
|
Sale | 19,275 | Sep 01, 2021 | Sept. 26, 2021, 8 p.m. |
|
ARVN
|
Sale | 11,863 | Sep 01, 2021 | Sept. 26, 2021, 8 p.m. |
|
ARVN
|
Sale | 28,449 | Sep 02, 2021 | Sept. 26, 2021, 8 p.m. |
|
ARVN
|
Sale | 23,316 | Sep 02, 2021 | Sept. 26, 2021, 8 p.m. |
|
ARVN
|
Sale | 30,068 | Sep 03, 2021 | Sept. 26, 2021, 8 p.m. |
|
ARVN
|
Sale | 2,319 | Sep 03, 2021 | Sept. 26, 2021, 8 p.m. |
|
ARVN
|
Sale | 14,751 | Sep 07, 2021 | Sept. 26, 2021, 8 p.m. |
|
ARVN
|
Sale | 5,467 | Sep 07, 2021 | Sept. 26, 2021, 8 p.m. |
|
ARVN
|
Sale | 14,163 | Sep 07, 2021 | Sept. 26, 2021, 8 p.m. |
RLYB
|
Purchase | 76,923 | Aug 02, 2021 | Aug. 3, 2021, 8 p.m. |
$ARVN Executives and Stock Owners with Insider Trades
-
John G Houston, President and CEO
-
Ian Taylor, Chief Scientific Officer
-
Ronald Peck, Chief Medical Officer
-
Sean A Cassidy, Chief Financial Officer
-
Angela M Cacace, Chief Scientific Officer
-
David K Loomis, Chief Accounting Officer
-
Ian Taylor, President, R&D
-
Andrew Saik, Chief Financial Officer
-
Noah Berkowitz, Chief Medical Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.